Opportunity
SAM #RFQ_CBER-2026-135968
FDA Solicitation for High-Density 2D Multi-Electrode Array Electrophysiology Platform and Support Services
Buyer
FDA Office of the Associate General Counsel for Administrative Law
Posted
September 14, 2026
Respond By
September 23, 2026
Identifier
RFQ_CBER-2026-135968
NAICS
334516, 334510, 541715
The FDA's Center for Drug Evaluation and Research (CDER), Division of Applied Regulatory Science (DARS), is soliciting quotations for a high-density 2D multi-electrode array (MEA) electrophysiology platform to support neural activity research in human iPSC-derived neuronal cultures and brain slices. - Government Buyer: - Food and Drug Administration (FDA) - Center for Drug Evaluation and Research (CDER) - Division of Applied Regulatory Science (DARS) - Products and Quantities Requested: - One complete high-density 2D MEA electrophysiology platform (includes workstation, hardware, accessories) - One perpetual software license for acquisition and analysis - Five initial compatible high-density recording plates/chips - Services and Support: - On-site installation, system verification, calibration, and pre-installation coordination - On-site hands-on operator training and demonstration for up to two personnel - Two-year manufacturer warranty (parts, labor, travel, repair, technical support) - Three optional one-year periods for annual preventative maintenance and repair after warranty expiration - Unique/Notable Requirements: - Platform must support simultaneous recording from thousands of electrodes - Must include electrical stimulation capability, environmental controls, and integrated analysis software - Delivery and consumables required within 60 days of award; installation and training within 75 days - Subject to Trade Agreements Act; offerors must provide country of origin for all products - No specific OEMs or part numbers are named in the solicitation; technical acceptability is evaluated on a pass/fail basis, with award to the lowest priced technically acceptable offeror.
Description
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), is issuing this combined synopsis/solicitation for the acquisition of a 2D High-Density Multi-Electrode Array (MEA) Electrophysiology Platform, including required hardware, software, accessories, initial consumables, installation, system verification, calibration, training, warranty coverage, and preventative maintenance option periods.
This solicitation is issued as a Request for Quotation (RFQ) for commercial products and services. This announcement constitutes the only solicitation; quotations are being requested, and a separate written solicitation will not be issued.
This requirement is being solicited on an unrestricted basis.
NAICS Code: 334516 – Analytical Laboratory Instrument Manufacturing PSC: 6640 – Laboratory Equipment and Supplies Set-Aside: None – Unrestricted Basis for Award: Lowest Price Technically Acceptable (LPTA)
Award will be made to the responsible offeror whose quotation is determined to be technically acceptable and represents the lowest evaluated price. Technical acceptability will be evaluated on a pass/fail basis against the minimum requirements identified in the solicitation and attached Requirements Document. Quotations that fail to meet any mandatory minimum requirement may be determined technically unacceptable and will not be considered for award.
The solicitation includes a base requirement consisting of the equipment and associated supplies/services, a two-year warranty from final Government acceptance, and three one-year option periods for preventative maintenance and repair services.
The solicitation is subject to the Trade Agreements Act. Offerors shall provide the country of origin for all offered end products and complete all applicable representations and certifications.
Questions: All questions regarding this solicitation shall be submitted in writing no later than September 17, 2026, at 10:00 AM Eastern Time. Questions received after the deadline may not be answered. Responses to questions may be posted through an amendment to the solicitation.
Quotation Due Date: Quotations shall be submitted no later than September 23, 2026, at 10:00 AM Eastern Time.
Offerors shall submit a complete quotation that includes, at a minimum, technical documentation demonstrating compliance with the solicitation requirements, completed technical compliance information, pricing for the base requirement and all option periods, warranty information, delivery lead time, country of origin for all offered items, UEI, and confirmation of active SAM.gov registration.
All solicitation documents, attachments, amendments, and Government responses to questions will be posted to SAM.gov. Offerors are responsible for monitoring SAM.gov for amendments or other updates to this solicitation.